Importance of the intestine as a site of metformin‐stimulated glucose utilization
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The intestine has been implicated as a site of increased glucose utilization by the antihyperglycaemic drug, metformin. This study makes a quantitative assessment of this effect. Glucose utilization by the intestine and hind limb region was determined by arterial‐venous glucose difference adjusted for blood flow rate in fasted rats receiving a hyperglycaemic hyperinsulinaemic infusion. Intrajejunal administration of metformin, 250 mg kg−1, increased glucose disposal during the infusion procedure, associated with increased glucose utilization in the intestine by 69% and in the hind limb region by 40%. Metformin, 250 mg kg−1, increased glucose disappearance during an intravenous glucose tolerance test. This was accompanied by increased uptake of tritiated 2‐deoxy‐d‐glucose into the intestinal mucosa to a greater extent than into skeletal muscles (per unit wet weight of tissue). The results demonstrate that the intestinal mucosa is a quantitatively important site of increased glucose utilization during the blood glucose‐lowering effect of metformin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
Ferrannini, E., Bjorkman, O., Reichard, G. A., Pilo, A., Olsson, M., Wahren, J., & DeFronzo, R. A. (1985) · Diabetes · doi:10.2337/diab.34.6.580 · Cited by 439
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Self-citationSynergistic interaction between exercise and insulin on peripheral glucose uptake.
DeFronzo, R. A., Ferrannini, E., Sato, Y., Felig, P., & Wahren, J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110399 · Cited by 415
Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects
DEFRONZO, R. A., BARZILAI, N., & SIMONSON, D. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1294 · Cited by 408
Cited by
The mechanisms of action of metformin
Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287
Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
“Although it may be difficult to wash out all the extracellular drug within the brush border, it does appear that the concentrations within the small intestine tissue aremuch higher than in other tissues or in plasma, raising the possibility that a significant site of action of metformin may be in the small intestine.(…”
BackgroundMetformin: historical overview
Bailey, C. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4318-z · Cited by 1,055
Self-citationCellular and Molecular Mechanisms of Metformin Action
LaMoia, T. E., & Shulman, G. I. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa023 · Cited by 791
Metadata
- Authors
- Bailey, C. J., Mynett, K. J., & Page, T.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1994-06
- Volume
- 112
- Issue
- 2
- Pages
- 671-675
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2006921940
- Cited by
- 147
- References
- 4
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Importance of the intestine as a site of metformin‐stimulated glucose utilization. https://app.cochat.ai/papers/10.1111/j.1476-5381.1994.tb13128.x
- The paper
- Bailey, C. J., Mynett, K. J., & Page, T. (1994). Importance of the intestine as a site of metformin‐stimulated glucose utilization. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1994.tb13128.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.